Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,445 Cr₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr

What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS is ₹3,445 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,445 Cr
Mar2025₹-828 Cr
Mar2024₹-265 Cr
Mar2023₹625 Cr
Mar2022₹1,109 Cr

How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,445 Cr
Positive
Mar2025 ₹-828 Cr
Negative
Mar2024 ₹-265 Cr
Negative
Mar2023 ₹625 Cr
-43.59
Mar2022 ₹1,109 Cr -

Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,636.1 Cr -1.7% 0.6% 12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,394.0 Cr -2.3% -3.3% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,312.0 Cr 0.3% 16.3% 44.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,678.0 Cr 2.8% -0.5% 37.1% Stock Analytics
CIPLA ₹114,392.0 Cr -3.1% -1.2% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,740.5 Cr -2.9% -3% -3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.7%

0.6%

12.2%

SENSEX

-1.4%

-1%

-4.6%


You may also like the below Video Courses